scispace - formally typeset
Open AccessJournal Article

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

Hope Hope Study Investigators, +1 more
- 01 Jan 2000 - 
- Vol. 22, Iss: 355, pp 253-259
TLDR
Ramipril was beneficial for cardiovascular events and overt nephropathy in people with diabetes and the cardiovascular benefit was greater than that attributable to the decrease in blood pressure.
About
This article is published in The Lancet.The article was published on 2000-01-01 and is currently open access. It has received 2307 citations till now. The article focuses on the topics: Ramipril.

read more

Citations
More filters
Journal ArticleDOI

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal ArticleDOI

Biochemistry and molecular cell biology of diabetic complications

TL;DR: This integrating paradigm provides a new conceptual framework for future research and drug discovery in diabetes-specific microvascular disease and seems to reflect a single hyperglycaemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain.
References
More filters
Journal ArticleDOI

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

TL;DR: Findings emphasize the need for rigorous sustained intervention in people with diabetes to control blood pressure, lower serum cholesterol, and abolish cigarette smoking, and the importance of considering nutritional-hygienic approaches on a mass scale to prevent diabetes.
Journal ArticleDOI

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

TL;DR: Whether captopril has kidney-protecting properties independent of its effect on blood pressure in diabetic nephropathy is determined.
Journal ArticleDOI

Diabetes and cardiovascular disease: The Framingham study

TL;DR: For each of the cardiovascular diseases (CVD), morbidity and mortality were higher for diabetic women than for nondiabetic men and for CVD death and CHF, it was greater for women.
Journal Article

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, +262 more
- 12 Sep 1998 - 
TL;DR: This study provided no evidence that either drug has any specific beneficial or deleterious effect, suggesting that blood pressure reduction in itself may be more important than the treatment used.
Related Papers (5)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, +262 more
- 12 Sep 1998 - 

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Stearne, +263 more
- 01 Jan 1998 -